Loss of Cell Polarity Drives Tumor Growth and Invasion Through JNK Activation in Drosophila
Overview
Affiliations
Apparent defects in cell polarity are often seen in human cancer. However, the underlying mechanisms of how cell polarity disruption contributes to tumor progression are unknown. Here, using a Drosophila genetic model for Ras-induced tumor progression, we show a molecular link between loss of cell polarity and tumor malignancy. Mutation of different apicobasal polarity genes activates c-Jun N-terminal kinase (JNK) signaling and downregulates the E-cadherin/beta-catenin adhesion complex, both of which are necessary and sufficient to cause oncogenic Ras(V12)-induced benign tumors in the developing eye to exhibit metastatic behavior. Furthermore, activated JNK and Ras signaling cooperate in promoting tumor growth cell autonomously, as JNK signaling switches its proapoptotic role to a progrowth effect in the presence of oncogenic Ras. Our finding that such context-dependent alterations promote both tumor growth and metastatic behavior suggests that metastasis-promoting mutations may be selected for based primarily on their growth-promoting capabilities. Similar oncogenic cooperation mediated through these evolutionarily conserved signaling pathways could contribute to human cancer progression.
Flamingo participates in multiple models of cell competition.
Bosch P, Cho B, Axelrod J Elife. 2025; 13.
PMID: 39854621 PMC: 11684786. DOI: 10.7554/eLife.98535.
An expanded view of cell competition.
Khandekar A, Ellis S Development. 2024; 151(22).
PMID: 39560103 PMC: 11607697. DOI: 10.1242/dev.204212.
Blockade of Crk eliminates Yki/YAP-activated tumors via JNK-mediated apoptosis in Drosophila.
Kakemura B, Igaki T Commun Biol. 2024; 7(1):1196.
PMID: 39341909 PMC: 11438906. DOI: 10.1038/s42003-024-06897-w.
Kodra A, Singh A, de la Cova C, Ziosi M, Johnston L Genetics. 2024; 228(1).
PMID: 38985651 PMC: 11373512. DOI: 10.1093/genetics/iyae107.
Waghmare I, Gangwani K, Rai A, Singh A, Kango-Singh M Cancers (Basel). 2024; 16(9).
PMID: 38730720 PMC: 11083887. DOI: 10.3390/cancers16091768.